Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck by Ronan W. Hsieh, Steven Borson, Anastasia Tsagianni, Dan P. Zandberg

Get full text

Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck by Greg M Delgoffe, Kristin DePeaux, Angen Liu, Dan P Zandberg, Ashley V Menk, Maria Velez, Daniel Normolle

Get full text

Small extracellular vesicles as biomarkers of response in recurrent/metastatic HNSCC patients treated with immunotherapy by Dan P. Zandberg, Chang-Sook Hong, Andrew Swartz, Ronan Hsieh, Jennifer Anderson, Robert L. Ferris, Brenda Diergaarde, Theresa L. Whiteside

Get full text

Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults by Dan P. Zandberg, Ting-Ying Huang, Xuehua Ke, Maria R. Baer, Steven D. Gore, Sheila Weiss Smith, Amy J. Davidoff

Get full text

Quality of life after radiation and transoral robotic surgery in advanced oropharyngeal cancer by Thomas M. Kaffenberger, Ankur K. Patel, Lingyun Lyu, Jinhong Li, Tamara Wasserman‐Wincko, Dan P. Zandberg, David A. Clump, Jonas T. Johnson, Marci L. Nilsen

Get full text

547 Reprogramming of type I interferon-responding tumor-reactive T lymphocytes associates with improved outcomes to neoadjuvant doublet immunotherapy in HNSCC by Lazar Vujanovic, Riyue Bao, Uma Duvvuri, Seungwon Kim, Robert Ferris, Aditi Kulkarni, Patricia Santos, Dan P Zandberg, Simon Chiosea, Housaiyin Li, Brian Isett, Joy Marion, Mark Kubik

681 innovaTV 207 Parts E and F: a phase 2 study of tisotumab vedotin in patients with head and neck squamous cell carcinoma (trial in progress) by Christine H Chung, Lara A Dunn, Ibrahima Soumaoro, Leonardo Nicacio, Dan P Zandberg, Douglas Adkins, Tanguy Y Seiwert, Nabil F Saba, Lova Sun, Thomas J George, William N William, Kristi Schmidt

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) by Andrew G. Sikora, Kevin J. Harrington, R. Bryan Bell, Maura L. Gillison, Quynh-Thu Le, Nancy Y. Lee, Rebecca L. Lewis, Loren K. Mell, Adam Raben, Ravindra Uppaluri, Fernanda Whitworth, Dan P. Zandberg

Get full text

Predictors and Consequences of Cancer and Non-Cancer-Related Pain in Those Diagnosed with Primary and Metastatic Cancers by Kriti Shah, David A. Geller, Samer Tohme, Michael Antoni, Cramer J. Kallem, Yoram Vodovotz, Rekha Ramanathan, Raam Naveen, MacKenzie Geroni, LaNita Devine, Aarshati Amin, Gauri J. Kiefer, Dan P. Zandberg, Vincent Reyes, Jennifer L. Steel

Get full text

Morphine treatment restricts response to immunotherapy in oral squamous cell carcinoma by Robert L Ferris, Tullia C Bruno, Dan P Zandberg, Lisa A McIlvried, Andre A Martel Matos, Marci L Nilsen, Sebastien Talbot, David N Taggart, Lorin K Johnson, Nicole N Scheff, Mona M Yuan, Megan A Atherton, Fendi Obuekwe, Amin Reza Nikpoor

Get full text

Definitive local therapy to head and neck squamous cell carcinoma with distant metastasis by Steven Borson, Yongli Shuai, Barton F. Branstetter, Marci Lee Nilsen, Marion A. Hughes, Moon Fenton, Mark Kubik, Shaum Sridharan, David A. Clump, Heath D. Skinner, Jonas T. Johnson, Simion I. Chiosea, James Ohr, Umamaheswar Duvvuri, Seungwon Kim, Katie S. Traylor, Robert Ferris, Dan P. Zandberg

Get full text

Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial by Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani

Get full text